Key Takeaway: Sanofi reported its total number of voting rights and shares as of October 2026. The company has a registered share capital of €2,415,546,786 and adheres to French commercial regulations. This information is accessible on Sanofi's investor website.
Price reaction · baseline $48.655 (2026-11-12T17:29:00.000Z) · hit during market hours · clean, no other SNY news in the window
day 0 close · peak
-0.4%
Market Sentiment Analysis
POSITIVE FACTORS
Sanofi maintains a strong share capital of €2,415,546,786.
The company complies with French regulatory requirements.
Information is transparently available on their website.
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+24%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Frexalimab
Phase 2 · Focal Segmental Glomerulosclerosis
Full Press Release Details
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’Autorité des Marchés Financiers (Regulation of the French stock market authority)
Sanofi a French société anonyme with a registered share capital of €2,415,546,786 Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris Commercial and Companies Registry under number 395 030 844
Date
Total number of issued shares
Number of real voting rights (excluding treasury shares)
Theoretical number of voting rights (including treasury shares)*
October 31, 2026
1,207,773,393
1,336,006,817
1,343,173,879
* Pursuant to Article 223-11 of the Règlement général de l’Autorité des Marchés Financiers.
This information is also available on the internet website of sanofi: